BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Drevets WC, Wittenberg GM, Bullmore ET, Manji HK. Immune targets for therapeutic development in depression: towards precision medicine. Nat Rev Drug Discov 2022. [PMID: 35039676 DOI: 10.1038/s41573-021-00368-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 von Mücke-Heim IA, Deussing JM. The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside. Neuropharmacology 2023;224:109366. [PMID: 36470368 DOI: 10.1016/j.neuropharm.2022.109366] [Reference Citation Analysis]
2 Wang C, Zhou Y, Feinstein A. Neuro-immune crosstalk in depressive symptoms of multiple sclerosis. Neurobiol Dis 2023;177:106005. [PMID: 36680805 DOI: 10.1016/j.nbd.2023.106005] [Reference Citation Analysis]
3 Turek J, Gąsior Ł. Estrogen fluctuations during the menopausal transition are a risk factor for depressive disorders. Pharmacol Rep 2023. [PMID: 36639604 DOI: 10.1007/s43440-022-00444-2] [Reference Citation Analysis]
4 Sun J, Guo C, Ma Y, Gao S, Luo Y, Chen Q, Hong Y, Hou X, Xiao X, Yu X, Rong P, Fang J. Immediate modulatory effects of transcutaneous auricular vagus nerve stimulation on the resting state of major depressive disorder. J Affect Disord 2023;325:513-21. [PMID: 36642310 DOI: 10.1016/j.jad.2023.01.035] [Reference Citation Analysis]
5 Simon MS, Arteaga-Henríquez G, Fouad Algendy A, Siepmann T, Illigens BMW. Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses. Neuropsychiatr Dis Treat 2023;19:1-25. [PMID: 36636142 DOI: 10.2147/NDT.S385117] [Reference Citation Analysis]
6 Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG. Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis. Int J Clin Health Psychol 2023;23:100349. [PMID: 36605409 DOI: 10.1016/j.ijchp.2022.100349] [Reference Citation Analysis]
7 Wan J, Shin DB, Syed MN, Abuabara K, Lemeshow AR, Gelfand JM. Atopic dermatitis and risk of major neuropsychiatric disorders in children: A population-based cohort study. J Eur Acad Dermatol Venereol 2022. [PMID: 36018560 DOI: 10.1111/jdv.18564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Greener M. New antidepressants: monoamines and beyond. Prescriber 2023;34:17-20. [DOI: 10.1002/psb.2032] [Reference Citation Analysis]
9 Batsukh S, Oh S, Rheu K, Lee BJ, Park CH, Son KH, Byun K. Rice Germ Ameliorated Chronic Unpredictable Mild Stress-Induced Depressive-like Behavior by Reducing Neuroinflammation. Nutrients 2022;14. [PMID: 36558541 DOI: 10.3390/nu14245382] [Reference Citation Analysis]
10 Goldsmith D, Bekhbat M, Mehta ND, Felger JC. Inflammation-related functional and structural dysconnectivity as a pathway to psychopathology. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.11.003] [Reference Citation Analysis]
11 Zhang J, Xie S, Chen Y, Zhou X, Zheng Z, Yang L, Li Y. Comprehensive analysis of endoplasmic reticulum stress and immune infiltration in major depressive disorder. Front Psychiatry 2022;13. [DOI: 10.3389/fpsyt.2022.1008124] [Reference Citation Analysis]
12 Zhou L, Xiong JY, Chai YQ, Huang L, Tang ZY, Zhang XF, Liu B, Zhang JT. Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system. Front Psychiatry 2022;13:933704. [PMID: 36117650 DOI: 10.3389/fpsyt.2022.933704] [Reference Citation Analysis]
13 Ma T, Sun Y, Wang L, Wang J, Wu B, Yan T, Jia Y. An Investigation of the Anti-Depressive Properties of Phenylpropanoids and Flavonoids in Hemerocallis citrina Baroni. Molecules 2022;27:5809. [DOI: 10.3390/molecules27185809] [Reference Citation Analysis]
14 Bode H, Ivens B, Bschor T, Schwarzer G, Henssler J, Baethge C. Hyperthyroidism and clinical depression: a systematic review and meta-analysis. Transl Psychiatry 2022;12:362. [PMID: 36064836 DOI: 10.1038/s41398-022-02121-7] [Reference Citation Analysis]
15 De Giorgi R, Cowen PJ, Harmer CJ. Statins in depression: a repurposed medical treatment can provide novel insights in mental health. International Review of Psychiatry. [DOI: 10.1080/09540261.2022.2113369] [Reference Citation Analysis]
16 Li QS, Galbraith D, Morrison RL, Trivedi MH, Drevets WC. Circulating microRNA associated with future relapse status in major depressive disorder. Front Psychiatry 2022;13:937360. [DOI: 10.3389/fpsyt.2022.937360] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Xu G, Zou T, Deng L, Yang G, Guo T, Wang Y, Niu C, Cheng Q, Yang X, Dong J, Zhang J. Nonerythropoietic Erythropoietin Mimetic Peptide ARA290 Ameliorates Chronic Stress-Induced Depression-Like Behavior and Inflammation in Mice. Front Pharmacol 2022;13:896601. [DOI: 10.3389/fphar.2022.896601] [Reference Citation Analysis]
18 Li W, Yang J, Pelusi D. Effect of Running Exercise on Brain Functional Magnetic Resonance Characteristics of College Students with Depression. Scanning 2022;2022:1-8. [DOI: 10.1155/2022/7558807] [Reference Citation Analysis]
19 Xiu J, Li J, Liu Z, Wei H, Zhu C, Han R, Liu Z, Zhu W, Shen Y, Xu Q. Elevated BICD2 DNA methylation in blood of major depressive disorder patients and reduction of depressive-like behaviors in hippocampal Bicd2-knockdown mice. Proc Natl Acad Sci U S A 2022;119:e2201967119. [PMID: 35858435 DOI: 10.1073/pnas.2201967119] [Reference Citation Analysis]
20 Kittur ME, Jones BDM, Dai N, Mahboob M, Husain MI. Repurposing Anti-inflammatory Agents for Mood Disorders: an Updated Review of Current Evidence. Curr Treat Options Psych 2022. [DOI: 10.1007/s40501-022-00267-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zhang MM, Guo MX, Zhang QP, Chen XQ, Li NZ, Liu Q, Cheng J, Wang SL, Xu GH, Li CF, Zhu JX, Yi LT. IL-1R/C3aR signaling regulates synaptic pruning in the prefrontal cortex of depression. Cell Biosci 2022;12:90. [PMID: 35715851 DOI: 10.1186/s13578-022-00832-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Vasiliu O. Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents. Front Pharmacol 2022;13:884143. [DOI: 10.3389/fphar.2022.884143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Dolotov OV, Inozemtseva LS, Myasoedov NF, Grivennikov IA. Stress-Induced Depression and Alzheimer’s Disease: Focus on Astrocytes. IJMS 2022;23:4999. [DOI: 10.3390/ijms23094999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Brewer-smyth K. COVID-19 Trauma: The New Complex Adverse Childhood Experience. Adverse Childhood Experiences 2022. [DOI: 10.1007/978-3-031-08801-8_7] [Reference Citation Analysis]
25 Brewer-smyth K. Trauma-Informed Self-care: Emotional and Spiritual Resilience and Healing. Adverse Childhood Experiences 2022. [DOI: 10.1007/978-3-031-08801-8_10] [Reference Citation Analysis]
26 Brewer-smyth K. Brain Food: The Impact of Diet, Nutrition, and Nutraceuticals on the Brain and the Microbiota-Gut-Brain Axis. Adverse Childhood Experiences 2022. [DOI: 10.1007/978-3-031-08801-8_12] [Reference Citation Analysis]